Exchangeable potassium (Ke) 
The calculated ECW did not change significantly in most cases. Only in one case was considerable overhydration present in the absence of heart disease. Significant intracellular deficit of potassium was probably not present in this series of patients.
There is little information available regarding the body composition in patients with Cushing's syndrome or in subjects on long-term cortisone treatment. Obesity is common in Cushing's syndrome and was the most constant clinical finding in the material of Ross et al. (1966) . Reduction of lean tissue is often clearly manifested as muscular wasting and osteoporosis in severe cases of hypercorticism (Albright 1942) . Oedema is not unusual in cases complicated by heart failure but may occur in the absence of heart disease. In the most rapidly developing cases of Cushing's syndrome, usually due to malignant disease in A difference between two single determinations of TBW must exceed 2.2 1 to be significant (P < 0.05). This figure was calculated from the predicted error given above (± 2.6 per cent).
Analysis of covariance was performed according to Snedecor (1956) .
RESULTS
The changes in body weight, Ke and TBW at different times after treatment are found in Tables 2 and 3 (Table 5) .
When compared with the figures for average normal body weight as pre¬ dicted from body height, our patients were only slightly overweight (Table 6) . On an average, the body weight was only eleven per cent higher than normal (range 2-25 per cent). In remission, the body weight was two per cent higher than predicted. In relation to height, Cases 29 and 37 were more overweight after than before treatment. In Table 6 (Cases 29, 34, 36, 41, 43 and 47). In these patients, Ke had not increased 4-12 months after treatment, i. e. at a time when they were in good condition ( (Table 4) , the BCM increased by 1.5-3.5 kg concomitantly with a decrease in body fat from 2 to 12 kg. It is true that those two subjects, who showed the most marked increase in BCM postopera¬ tively (Cases 29 and 37), did not exhibit any significant decrease in fat. They were both overweight, however, and had increased in weight during the development of the disease (Table 6 ). In Case 41, BCM did not increase after treatment but this patient also had osteoporosis and atrophy of the skin. There was no apparent relation between the degree of overweight (Table 6) (1957) . In the latter material, the chloride space was also measured and the calculated intracellular potassium concentration averaged 150 meq./l. On the basis of these findings it was assumed that the hydration of the fat free body was normal and body fat was accordingly calculated from the formula of Pace Sc Rathbun (1945) .
If the cellular concentration of potassium did not increase after treatment, the approximate changes in ECW, which occurred after treatment can be estimated. This was done on the assumption of a normal average intracellular concentration of 150 meq./l ( (Lindberg et al. 1956 ). After treatment obesity was still present in three patients (16, 22 and 31 per cent overweight).
As demonstrated by the body composition studies as well as by the clinical examination, muscular wasting disappeared or improved markedly after treat¬ ment. In contrast, no improvement has occurred in the radiological appearance of the skeleton. This is in agreement with the experience of other investigators (lannaccone et al. 1960 ).
